Phylogenetic analysis of human immunodeficiency virus type 1 subtype C Env gp120 sequences among four drug-naive families following subsequent heterosexual and vertical transmissions

AIDS Research and Human Retroviruses

Volumn 28, Issue 8, 2012, Pages 885-893

  Duri, Kerina ^a   Gumbo, Felicity ^a   Kristiansen, Knut ^b   Mapingure, Munyaradzi ^c   Munjoma, Marshall ^a   Chirenje, Mike ^a   Rusakaniko, Simbarashe ^a   Stray Pedersen, Babill ^d   Muller, Fredrik ^b  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b UNIVERSITY OF OSLO   (Norway)

^c Department of Bioinformatics   (Zimbabwe)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; NEVIRAPINE; PROTEIN VARIANT; VIRUS RNA;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BASE PAIRING; CHILD; COMPUTER PROGRAM; CONTROLLED STUDY; DONOR; FEMALE; GENE CLUSTER; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; PATERNALISM; PHYLOGENY; PRESCHOOL CHILD; PRIORITY JOURNAL; SAMPLE; SCHOOL CHILD; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEXUAL TRANSMISSION; SIBLING; SINGLE DRUG DOSE; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, INFECTIOUS; DNA, VIRAL; FAMILY; GENETIC VARIATION; HETEROSEXUALITY; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; YOUNG ADULT; ZIMBABWE;

EID: 84864229338     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0217     Document Type: Article

References (75)

1. Bartelsman M and Veeken H: [The HIV pandemic in the year 2007, an overview]. Ned Tijdschr Geneeskd 2007;151(48): 2655-2660.
2. Scarlatti G, Albert J, Rossi P, et al.: Mother-to-child transmission of human immunodeficiency virus type 1: Correlation with neutralizing antibodies against primary isolates. J Infect Dis 1993;168(1):207-210.
3. Wolfs TF, Zwart G, Bakker M, and Goudsmit J: HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 1992;189(1):103-110.
4. Biesinger T and Kimata JT: HIV-1 transmission, replication fitness and disease progression. Virology (Auckl) 2008;2008(1): 49-63.
5. Corey L, Wald A, Celum CL, and Quinn TC: The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: A review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004;35(5):435-445.
6. Ahmad N: Maternal-fetal transmission of human immunodeficiency virus. J Biomed Sci 1996;3(4):238-250.
7. Scott GB, Fischl MA, Klimas N, et al.: Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA 1985; 253(3):363-366.
8. Mok JQ, Giaquinto C, De RA, et al.: Infants born to mothers seropositive for human immunodeficiency virus. Preliminary findings from a multicentre European study. Lancet 1987;1(8543):1164-1168.
9. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al.: Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 2008;105(21):7552-7557.
10. Sagar M, Laeyendecker O, Lee S, et al.: Selection of HIV variants with signature genotypic characteristics during heterosexual transmission. J Infect Dis 2009;199(4):580-589.
11. Nowak P, Karlsson AC, Naver L, et al.: The selection and evolution of viral quasispecies in HIV-1 infected children. HIV Med 2002;3(1):1-11.
12. Frost SD, Liu Y, Pond SL, et al.: Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J Virol 2005;79(10):6523-6527.
13. Simmonds P, Balfe P, Ludlam CA, Bishop JO, and Brown AJ: Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol 1990;64(12):5840-5850.
14. Zhang LQ, MacKenzie P, Cleland A, et al.: Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 1993;67(6):3345-3356.
15. Karlsson AC, Gaines H, Sallberg M, Lindback S, and Sonnerborg A: Reappearance of founder virus sequence in human immunodeficiency virus type 1-infected patients. J Virol 1999;73(7):6191-6196.
16. Mullins JI and Jensen MA: Evolutionary dynamics of HIV-1 and the control of AIDS. Curr Top Microbiol Immunol 2006;299:171-192
17. Shankarappa R, Margolick JB, Gange SJ, et al.: Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999;73(12):10489-10502.
18. Delwart E, Magierowska M, Royz M, et al.: Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection. AIDS 2002;16(2):189-195.
19. Herbeck JT, Nickle DC, Learn GH, et al.: Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. J Virol 2006;80(4):1637-1644.
20. Long EM, Martin HL Jr, Kreiss JK, et al.: Gender differences in HIV-1 diversity at time of infection. Nat Med 2000;6(1): 71-75.
21. Sagar M, Lavreys L, Baeten JM, et al.: Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population. AIDS 2004;18(4):615-619.
22. Keele BF and Derdeyn CA: Genetic and antigenic features of the transmitted virus. Curr Opin HIV AIDS 2009;4(5):352-357.
23. Haaland RE, Hawkins PA, Salazar-Gonzalez J, et al.: Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog 2009;5(1):e1000274.
24. Contag CH, Ehrnst A, Duda J, et al.: Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes. J Virol 1997;71(2): 1292-1300.
25. Ahmad N, Baroudy BM, Baker RC, and Chappey C: Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol 1995;69(2):1001-1012.
26. Wolinsky SM, Wike CM, Korber BT, et al.: Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992;255(5048):1134-1137.
27. Wike CM, Korber BT, Daniels MR, et al.: HIV-1 sequence variation between isolates from mother-infant transmission pairs. AIDS Res Hum Retroviruses 1992;8(7):1297-1300.
28. van't Wout AB, Kootstra NA, Mulder-Kampinga GA, et al.: Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 1994;94(5):2060-2067.
29. Pasquier C, Cayrou C, Blancher A, et al.: Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1. J Virol 1998;72(11):8493-8501.
30. Lamers SL, Sleasman JW, She JX, et al.: Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission. J Clin Invest 1994;93(1):380-390.
31. Briant L, Wade CM, Puel J, Brown AJ, and Guyader M: Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1. J Virol 1995;69(6):3778-3788.
32. Dickover RE, Garratty EM, Plaeger S, and Bryson YJ: Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol 2001;75(5):2194-2203.
33. Verhofstede C, Demecheleer E, De CN, et al.: Diversity of the human immunodeficiency virus type 1 (HIV-1) env sequence after vertical transmission in mother-child pairs infected with HIV-1 subtype A. J Virol 2003;77(5):3050-3057.
34. Gumbo FZ, Kandawasvika GQ, Duri K, et al.: Reduced HIV transmission at subsequent pregnancy in a resource-poor setting. Trop Doct 2011;41(3):132-135.
35. Duri K, Soko W, Gumbo F, et al.: Genotypic analysis of human immunodeficiency virus type 1 env V3 loop sequences: Bioinformatics prediction of coreceptor usage among 28 infected mother-infant pairs in a drug-naive population. AIDS Res Hum Retroviruses 2011;27(4):411-419.
36. Tamura K, Peterson D, Peterson N, et al.: MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011;28(10):2731-2739.
37. Hillis DM, Bull JJ, White ME, Badgett MR, and Molineux IJ: Experimental phylogenetics: generation of a known phylogeny. Science 1992;255(5044):589-592.
38. Yamaguchi J, Bodelle P, Kaptue L, et al.: Near full-length genomes of 15 HIV type 1 group O isolates. AIDS Res Hum Retroviruses 2003;19(11):979-988.
39. Munjoma MW, Kurewa EN, Mapingure MP, et al.: The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth. BMC Womens Health 2010;10:2.
40. Ball SC, Abraha A, Collins KR, et al.: Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol 2003;77(2):1021-1038.
41. Marozsan AJ, Fraundorf E, Abraha A, et al.: Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates. J Virol 2004;78(20):11130-11141.
42. Kong X, West JT, Zhang H, et al.: The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses. J Virol 2008;82(23):11609-11618.
43. Abrahams MR, Anderson JA, Giorgi EE, et al.: Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol 2009;83(8):3556-3567.
44. Liu Y, Nonnemacher MR, Stauff DL, et al.: Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR. Biomed Pharmacother 2010;64(10):672-680.
45. Bar KJ, Li H, Chamberland A, et al.: Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol 2010;84(12):6241-6247.
46. Baeten JM and Overbaugh J: Measuring the infectiousness of persons with HIV-1: Opportunities for preventing sexual HIV-1 transmission. Curr HIV Res 2003;1(1):69-86.
47. Fideli US, Allen SA, Musonda R, et al.: Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 2001;17(10):901-910.
48. Pillai SK, Good B, Pond SK, et al.: Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol 2005;79(3):1734-1742.
49. Karlsson AC, Lindback S, Gaines H, and Sonnerborg A: Characterization of the viral population during primary HIV-1 infection. AIDS 1998;12(8):839-847.
50. Rademeyer C, Van Harmelen JH, Ramjee G, Karim SS, and Williamson C: Heterosexual transmission of multiple highly conserved viral variants in HIV-1 subtype C-infected seronegative women. AIDS 2004;18(15):2096-2098.
51. John-Stewart GC, Nduati RW, Rousseau CM, et al.: Subtype C is associated with increased vaginal shedding of HIV-1. J Infect Dis 2005;192(3):492-496.
52. Overbaugh J, Kreiss J, Poss M, et al.: Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya. J Infect Dis 1999;179(Suppl 3):S401-S404.
53. Renjifo B, Gilbert P, Chaplin B, et al.: Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS 2004;18(12):1629-1636.
54. Sundaravaradan V, Das SR, Ramakrishnan R, et al.: Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages. Virol J 2007;4:126.
55. Soares EA, Martinez AM, Souza TM, et al.: HIV-1 subtype C dissemination in southern Brazil. AIDS 2005;19(Suppl 4): S81-S86.
56. McCormack GP, Glynn JR, Crampin AC, et al.: Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi. J Virol 2002;76(24): 12890-12899.
57. Matala E, Crandall KA, Baker RC, and Ahmad N: Limited heterogeneity of HIV type 1 in infected mothers correlates with lack of vertical transmission. AIDS Res Hum Retroviruses 2000;16(15):1481-1489.
58. Panther LA, Tucker L, Xu C, et al.: Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission. J Infect Dis 2000;181(2):555-563.
59. Leslie A, Kavanagh D, Honeyborne I, et al.: Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J Exp Med 2005;201(6):891-902.
60. Cowan FM, Humphrey JH, Ntozini R, et al.: Maternal herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: Results of a case control study. AIDS 2008;22(2):193-201.
61. James MM, Wang L, Musoke P, et al.: Association of HIV diversity and survival in HIV-infected Ugandan infants. PLoS One 2011;6(4):e18642.
62. Luzuriaga K, Koup RA, Pikora CA, Brettler DB, and Sullivan JL: Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. J Pediatr 1991;119(2):230-236.
63. Buseyne F and Riviere Y: HIV-specific CD8 + T-cell immune responses and viral replication.AIDS 1993;7(Suppl 2):S81-S85.
64. Huang S, Dunkley-Thompson J, Tang Y, et al.: Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment. J Immunol 2008;181(11):8103-8111.
65. Thobakgale CF, Ramduth D, Reddy S, et al.: Human immunodeficiency virus-specific CD8 + T-cell activity is detectable from birth in the majority of in utero-infected infants. J Virol 2007;81(23):12775-12784.
66. Shalekoff S, Meddows-Taylor S, Gray GE, et al.: Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers. AIDS 2009;23(7):789-798.
67. Arien KK, Troyer RM, Gali Y, et al.: Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS 2005;19(15):1555-1564.
68. Keet IP, Veugelers PJ, Koot M, et al.: Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993. AIDS 1996;10(13):1601-1602.
69. Kourtis AP, Butera S, Ibegbu C, Beled L, and Duerr A: Breast milk and HIV-1: Vector of transmission or vehicle of protection? Lancet Infect Dis 2003;3(12):786-793.
70. Habte HH, De BC, Lotz ZE, et al.: Inhibition of human immunodeficiency virus type 1 activity by purified human breast milk mucin (MUC1) in an inhibition assay. Neonatology 2008;93(3):162-170.
71. Garofalo RP and Goldman AS: Cytokines, chemokines, and colony-stimulating factors in human milk: The 1997 update. Biol Neonate 1998;74(2):134-142.
72. Heath L, Conway S, Jones L, et al.: Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission. PLoS One 2010;5(4):e10213.
73. Gaschen B, Taylor J, Yusim K, et al.: Diversity considerations in HIV-1 vaccine selection. Science 2002;296(5577):2354-2360.
74. Kwiek JJ, Russell ES, Dang KK, et al.: The molecular epidemiology of HIV-1 envelope diversity during HIV-1 subtype C vertical transmission in Malawian mother-infant pairs. AIDS 2008;22(7):863-871.
75. Sagar M, Wu X, Lee S, and Overbaugh J: Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J Virol 2006;80(19):9586-9598.